EP 1001762 A4 20020508 - METHOD OF USING NEUROTROPHIC CARBAMATES AND UREAS
Title (en)
METHOD OF USING NEUROTROPHIC CARBAMATES AND UREAS
Title (de)
METHODE ZUR VERWENDUNG VON NEUROTHROPHISCHEN CARBAMATEN UND UREATEN
Title (fr)
METHODE D'UTILISATION DE CARBAMATES ET D'UREES NEUROTROPHIQUES
Publication
Application
Priority
- US 9803485 W 19980226
- US 80564697 A 19970227
Abstract (en)
[origin: WO9837882A1] This invention relates to a method of using neurotrophic low molecular weight, small molecule carbamates and ureas having an affinity for FKBP-type immunophilins, as inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
IPC 1-7
IPC 8 full level
A61K 31/17 (2006.01); A61K 31/27 (2006.01); A61K 31/4439 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 31/4439 (2013.01); A61P 25/00 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
- [E] WO 9820893 A1 19980522 - VERTEX PHARMA [US]
- [Y] WO 9641609 A2 19961227 - VERTEX PHARMA [US]
- [Y] WO 9640633 A1 19961219 - GUILFORD PHARM INC [US]
- [XY] WO 9526337 A1 19951005 - VERTEX PHARMA [US]
- See references of WO 9837882A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9837882 A1 19980903; AR 011869 A1 20000913; AU 6181698 A 19980918; CA 2281096 A1 19980903; EP 1001762 A1 20000524; EP 1001762 A4 20020508; JP 2001513772 A 20010904; PA 8447901 A1 20000524; PE 46599 A1 19990512; ZA 98825 B 19981019
DOCDB simple family (application)
US 9803485 W 19980226; AR P980100829 A 19980225; AU 6181698 A 19980226; CA 2281096 A 19980226; EP 98906647 A 19980226; JP 53775298 A 19980226; PA 8447901 A 19980226; PE 00011798 A 19980219; ZA 98825 A 19980202